The thing that strikes the most fear in the hearts of cancer patients is wondering if a remission is real, or if the cancer is just on pause. These fears linger despite the most aggressive treatments and the best doctors.

The genes you inherit from your parents can be sort of a mixed bag. While some traits like height and eye color can be straightforward, some are complex relationships that take a detective to find the full implications.

The last few decades have seen an incredible growth in the number and kinds of drugs used to treat cancer, including entirely new classes of drugs outside traditional chemotherapy.

Scientists have long observed that the same molecule can have a variety of different functions in the body depending on where it is at that moment.

Given the long list of side effects associated with traditional cancer treatments like chemotherapy and radiation, newer treatments focus on targets associated with the cancer that are as specific as possible.

Part of the treatment for especially severe cancers of the blood is to destroy all the cells in the bone marrow that are responsible for making both the good and bad parts of the blood with radiation therapy.

A recent study shows just how fragile the relationship between reported news and truth can be. The recent drop in reported myeloid leukemias over the last decade may be just a classification error.

Elderly patients with leukemia may not be able to tolerate chemotherapy as well as they once could, or simply may not want to deal with the serious side effects anymore.

Multiple myeloma  is a cancer of the blood cells. It grows in the bone marrow, and can cause long bones like the thigh bone (femur) and bones in the spine to break. Drug therapy with a class of drugs can help to prevent these fractures.

There are two main types of chronic lymphocytic leukemia, and knowing whether a patient has the aggressive or the slow version is very important to determine treatment early on.